NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1112,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "e7c6256d-d484-4263-8f0d-9898fa7c2aee",
"title": "CoStar Group Inc (CSGP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Acquisitions Set New Benchmarks",
"description": "Revenue: $656 million in Q1 2024, a 12% increase from Q1 2023.Net New Bookings: Reached an all-time high of $86 million in Q1 2024.Website Traffic: Record 170",
"keywords": "GuruFocus, Article, News, GuruFocus Research, CSGP",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Can you...",
"url": "https://www.gurufocus.com/news/2416375/costar-group-inc-csgp-q1-2024-earnings-call-transcript-highlights-robust-growth-and-strategic-acquisitions-set-new-benchmarks",
"image_url": "https://static.gurufocus.com/logos/0C00000ARF.png?5",
"language": "en",
"published_at": "2024-04-24T07:16:54.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CSGP",
"name": "CoStar Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 53.97065,
"sentiment_score": 0.7044,
"highlights": [
{
"highlight": "Florance, Founder, CEO & Director of <em>CoStar</em> <em>Group</em>, <em>Inc</em>., noted that Homes.com exceeded expectations, primarily driven by outbound efforts. There was strong inbound interest and significant sales at industry events. The sales cycle is notably fast, often closing simultaneously with demos.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "<em>CoStar</em> <em>Group</em> <em>Inc</em> (CSGP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Acquisitions Set New Benchmarks",
"sentiment": 0.6124,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "80c4fedd-7d86-437d-a718-1bfef6048aea",
"title": "AudioEye Inc (AEYE) Q1 2024 Earnings Call Transcript Highlights: Record Revenues and Strategic Growth Initiatives",
"description": "Revenue: Q1 2024 revenue reached $8.1 million, marking a 33rd consecutive quarter of record revenue.Annual Recurring Revenue (ARR): Ended Q1 2024 at $32 millio",
"keywords": "GuruFocus, Article, News, GuruFocus Research, AEYE",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Can you...",
"url": "https://www.gurufocus.com/news/2416363/audioeye-inc-aeye-q1-2024-earnings-call-transcript-highlights-record-revenues-and-strategic-growth-initiatives",
"image_url": "https://static.gurufocus.com/logos/0C00009W3Y.png?5",
"language": "en",
"published_at": "2024-04-24T07:14:09.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AEYE",
"name": "AudioEye, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 84.90378,
"sentiment_score": 0.602275,
"highlights": [
{
"highlight": "A: David Moradi, CEO of <em>AudioEye</em>, highlighted the company's readiness for upcoming regulatory changes, emphasizing their strong position with enterprise and reseller channels, and a full product suite that caters to both small businesses and large enterprises. He anticipates a significant uptick in demand by 2025 due to new regulations.",
"sentiment": 0.6808,
"highlighted_in": "main_text"
},
{
"highlight": "A: David Moradi explained that <em>AudioEye</em> has exclusive relationships with key resellers serving about 80,000 websites, mainly in the government sector. He sees a massive opportunity for growth, expecting near full penetration with these partners in the next two to three years.",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "A: Kelly Georgevich, CFO of <em>AudioEye</em>, mentioned growth in both existing and new reseller partnerships. She highlighted the continuous emergence of new resellers each quarter, contributing to the company's growth.\n\nQ: Can you talk about the key underlying factor that's driving the upside in terms of the adjusted EBITDA margin?",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AudioEye</em> <em>Inc</em> (AEYE) Q1 2024 Earnings Call Transcript Highlights: Record Revenues and Strategic Growth Initiatives",
"sentiment": 0.3818,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "1975dfd3-7fa6-4859-827b-560b6999b992",
"title": "Medpace Holdings Inc (MEDP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Optimistic Projections",
"description": "Revenue: Q1 2024 was $511 million, a 17.7% increase year-over-year.Net Income: $102.6 million in Q1 2024, up 40.7% from $72.9 million in Q1 2023.EBITDA: $115.7",
"keywords": "GuruFocus, Article, News, GuruFocus Research, MEDP",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Could y...",
"url": "https://www.gurufocus.com/news/2416340/medpace-holdings-inc-medp-q1-2024-earnings-call-transcript-highlights-robust-growth-and-optimistic-projections",
"image_url": "https://static.gurufocus.com/logos/0C0000B4MW.png?5",
"language": "en",
"published_at": "2024-04-24T07:08:38.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MEDP",
"name": "Medpace Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 116.56783,
"sentiment_score": 0.397757,
"highlights": [
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Sequentially, gross bookings were up nicely in the quarter. The miss was driven by cancellations that were outside of our usual range, which is typically less than 4.5%. Without these cancellations, bookings growth would have been in line with our expectations.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) The funding environment has improved from last year, and there are good business opportunities moving forward. While some clients are still struggling, the overall environment is much better, leading to optimism for the year.",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "Brady - CFO & Treasurer, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Reimbursable costs are volatile and influenced by various factors including study mix, site start-ups, and inflationary costs. We expect these costs to align with last year's percentage of revenue, but the first quarter was weaker, leading us to lean towards the lower end of our revenue guidance.",
"sentiment": -0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) The lower rate of employee growth is influenced by improvements in productivity and optimization of staffing, not by a change in optimism about 2025. We continue to hire at a rate that supports our current and future projects.",
"sentiment": 0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Short-term, M&A activity does not significantly impact our performance. Long-term, it could potentially affect our client base, but typically, we manage to maintain our bookings and revenue from ongoing projects.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Yes, the change is due to significant investments in productivity improvements. We expect these gains to be sustainable and to contribute to operating leverage as we move into 2025 and beyond.",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medpace</em> <em>Holdings</em> <em>Inc</em> (MEDP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Optimistic Projections",
"sentiment": 0.743,
"highlighted_in": "title"
}
]
},
{
"symbol": "MEDP.MX",
"name": "Medpace Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 116.55589,
"sentiment_score": 0.397757,
"highlights": [
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Sequentially, gross bookings were up nicely in the quarter. The miss was driven by cancellations that were outside of our usual range, which is typically less than 4.5%. Without these cancellations, bookings growth would have been in line with our expectations.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) The funding environment has improved from last year, and there are good business opportunities moving forward. While some clients are still struggling, the overall environment is much better, leading to optimism for the year.",
"sentiment": 0.9042,
"highlighted_in": "main_text"
},
{
"highlight": "Brady - CFO & Treasurer, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Reimbursable costs are volatile and influenced by various factors including study mix, site start-ups, and inflationary costs. We expect these costs to align with last year's percentage of revenue, but the first quarter was weaker, leading us to lean towards the lower end of our revenue guidance.",
"sentiment": -0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) The lower rate of employee growth is influenced by improvements in productivity and optimization of staffing, not by a change in optimism about 2025. We continue to hire at a rate that supports our current and future projects.",
"sentiment": 0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Short-term, M&A activity does not significantly impact our performance. Long-term, it could potentially affect our client base, but typically, we manage to maintain our bookings and revenue from ongoing projects.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: (August James Troendle - Chairman & CEO, <em>Medpace</em> <em>Holdings</em>, <em>Inc</em>.) Yes, the change is due to significant investments in productivity improvements. We expect these gains to be sustainable and to contribute to operating leverage as we move into 2025 and beyond.",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Medpace</em> <em>Holdings</em> <em>Inc</em> (MEDP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Optimistic Projections",
"sentiment": 0.743,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "3e21039b-1903-4264-893d-2124b73f98a3",
"title": "Tesla Inc (TSLA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Expanding Horizons",
"description": "Revenue: Declined quarter-over-quarter due to seasonality and uncertain macroeconomic conditions.Auto Margins: Decreased from 18.9% to 18.5%, excluding Cybertr",
"keywords": "GuruFocus, Article, News, GuruFocus Research, TSLA",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: What is...",
"url": "https://www.gurufocus.com/news/2416373/tesla-inc-tsla-q1-2024-earnings-call-transcript-highlights-navigating-challenges-and-expanding-horizons",
"image_url": "https://static.gurufocus.com/logos/0C00004EP4.png?5",
"language": "en",
"published_at": "2024-04-24T07:16:18.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 51.911392,
"sentiment_score": 0.10352,
"highlights": [
{
"highlight": "<em>Tesla</em> plans to stay ahead of Cybertruck production needs by ramping up additional production lines and maintaining a buffer of cell inventory.\n\nQ: What is the current status of the Optimus project, and are these robots performing any factory tasks? When is mass production expected?",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "A: (Elon Musk - CEO & Director) Optimus robots are currently performing simple tasks in the lab and are expected to be doing useful tasks in <em>Tesla</em> factories by the end of this year. Mass production and external sales are anticipated by the end of next year.",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Q: Can you provide an update on the timeline and expectations for the $25,000 <em>Tesla</em> vehicle?\n\nA: (Lars Moravy - VP of Vehicle Engineering and Elon Musk - CEO & Director) The launch of Tesla's more affordable vehicle models has been accelerated, with production expected to start using existing lines and open capacity.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Q: Have any legacy automakers approached <em>Tesla</em> about licensing Full Self-Driving technology?\n\nA: (Elon Musk - CEO & Director) <em>Tesla</em> is currently in discussions with one major automaker about licensing FSD technology. This indicates a potential expansion of Tesla's technology into broader automotive applications.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tesla</em> <em>Inc</em> (TSLA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Expanding Horizons",
"sentiment": 0.0772,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "a2afa26c-3ecb-468f-8ad8-7799a114d746",
"title": "Option Care Health Inc (OPCH) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with Resilience",
"description": "Revenue Growth: Over 12% increase.Patient Satisfaction: Remains strong at 93% with a Net Promoter Score of 76.2.Chronic Therapy Growth: Mid-teens growth, outpa",
"keywords": "GuruFocus, Article, News, GuruFocus Research, OPCH",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nPositive Points\n\nOption Care...",
"url": "https://www.gurufocus.com/news/2416320/option-care-health-inc-opch-q1-2024-earnings-call-transcript-highlights-navigating-challenges-with-resilience",
"image_url": "https://static.gurufocus.com/logos/0C000006XG.png?5",
"language": "en",
"published_at": "2024-04-24T07:03:53.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "OPCH",
"name": "Option Care Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 130.88942,
"sentiment_score": 0.452033,
"highlights": [
{
"highlight": "Positive Points\n\n<em>Option</em> <em>Care</em> <em>Health</em> <em>Inc</em> (OPCH, Financial) reported a strong revenue growth of over 12% in the first quarter, reflecting solid execution and dedication of its team.\n\nPatient satisfaction remains high at 93%, with a Net Promoter Score of 76.2, indicating strong performance in patient care despite challenges.",
"sentiment": 0.9607,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Option</em> <em>Care</em> <em>Health</em> <em>Inc</em> (OPCH) demonstrated resilience and agility by quickly developing workarounds during the Change Healthcare incident, which helped maintain operations and strengthen relationships with referral sources.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Option</em> <em>Care</em> <em>Health</em> <em>Inc</em> (OPCH) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with Resilience",
"sentiment": 0.0772,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "178bca6c-b777-4377-9d0d-108f03ccb5af",
"title": "LKQ Corp (LKQ) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Capitalizing on Opportunities",
"description": "Revenue: $3.7 billion in Q1 2024, up 10.6% from $3.3 billion in Q1 2023.Parts and Services Revenue: Increased by 12.1% year-over-year.Other Revenue: Decreased",
"keywords": "GuruFocus, Article, News, GuruFocus Research, LKQ",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Nick, a...",
"url": "https://www.gurufocus.com/news/2416311/lkq-corp-lkq-q1-2024-earnings-call-transcript-highlights-navigating-challenges-and-capitalizing-on-opportunities",
"image_url": "https://static.gurufocus.com/logos/0C0000084R.png?5",
"language": "en",
"published_at": "2024-04-24T07:01:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LKQ",
"name": "LKQ Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 24.009212,
"sentiment_score": 0.58368,
"highlights": [
{
"highlight": "Zarcone - <em>LKQ</em> <em>Corporation</em> - President, CEO & Director) Thanks, Craig.\n\nQ: My question goes to your comments around insurance prices. I'm just curious if you could walk through how higher and really significantly higher insurance prices impact your business overall.\n\nA: (Justin L. Jude - <em>LKQ</em> <em>Corporation</em> - Executive VP & COO) Yes.",
"sentiment": 0.8918,
"highlighted_in": "main_text"
},
{
"highlight": "A: (Rick Galloway - <em>LKQ</em> <em>Corporation</em> - Senior VP & CFO) Yes, Gary, fair question. So when we talked about it in the closing of Q4 for the guidance for this year, we said we'd be around 17% for the year with the dilution on Uni-Select.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "A: (Rick Galloway - <em>LKQ</em> <em>Corporation</em> - Senior VP & CFO) So let me just go high level, and then I'll turn it over to you, Justin. I know you've been spending a lot of time out there. So Scott, I appreciate the question. If you think year-over-year, the biggest impact that we had on overall EBITDA margins is really the inflationary impact of wages.",
"sentiment": 0.4549,
"highlighted_in": "main_text"
},
{
"highlight": "Jude - <em>LKQ</em> <em>Corporation</em> - Executive VP & COO) Yes. And Scott, like some of the markets such as the Benelux area or even in Germany, we're seeing mid-teen increases in labor rates and it's a market issue. That happens immediately.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
},
{
"highlight": "Jude - <em>LKQ</em> <em>Corporation</em> - Executive VP & COO) Yes. Once again, overall, I mean, from the stats that we can see externally, we think it's mostly contributed to weather. I'm not sure I don't have the facts in front of me from 2017.",
"sentiment": 0.3224,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "e4ce5f2a-7bd2-44d9-a455-42e6ca7f79fd",
"title": "East West Bancorp Inc (EWBC) (Q1 2024) Earnings Call Transcript Highlights: Strong Performance Amid Economic Shifts",
"description": "Net Income: $285 million for Q1 2024.Earnings Per Share (EPS): $2.03 per diluted share; adjusted EPS $2.08.Asset Growth: Average assets and loans grew by 1%.De",
"keywords": "GuruFocus, Article, News, GuruFocus Research, EWBC",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: What's ...",
"url": "https://www.gurufocus.com/news/2416372/east-west-bancorp-inc-ewbc-q1-2024-earnings-call-transcript-highlights-strong-performance-amid-economic-shifts",
"image_url": "https://static.gurufocus.com/logos/0C00000B2S.png?5",
"language": "en",
"published_at": "2024-04-24T07:16:09.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EWBC",
"name": "East West Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 131.52269,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "<em>East</em> <em>West</em> <em>Bancorp</em> <em>Inc</em> (EWBC) (Q1 2024) Earnings Call Transcript Highlights: Strong Performance Amid Economic Shifts",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "b8693cfe-68f5-42e1-937c-012ac5a3b50a",
"title": "Sandy Spring Bancorp Inc (SASR) Q1 2024 Earnings Call Transcript Highlights: A Detailed Financial Overview",
"description": "Net Income: $20.4 million for Q1 2024, down from $26.1 million in Q4 2023 and $51.3 million in Q1 2023.Earnings Per Share (EPS): $0.45 per diluted common share",
"keywords": "GuruFocus, Article, News, GuruFocus Research, SASR",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Can you...",
"url": "https://www.gurufocus.com/news/2416364/sandy-spring-bancorp-inc-sasr-q1-2024-earnings-call-transcript-highlights-a-detailed-financial-overview",
"image_url": "https://static.gurufocus.com/logos/0C000008WH.png?5",
"language": "en",
"published_at": "2024-04-24T07:14:13.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SASR",
"name": "Sandy Spring Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 153.09079,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Sandy</em> <em>Spring</em> <em>Bancorp</em> <em>Inc</em> (SASR) Q1 2024 Earnings Call Transcript Highlights: A Detailed Financial Overview",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "8853fe70-d0d9-4073-8604-f34b50147b19",
"title": "Q1 2024 East West Bancorp Inc Earnings Call Transcript",
"description": "Apr 23, 2024 / 09:00PM GMTOperator Good day. Welcome to the East West Bancorp's First Quarter 2024 Earnings Call. (Operator Instructions) Please note, this even",
"keywords": "GuruFocus, Article, News, GuruFocus Research, NAS:EWBC",
"snippet": "Apr 23, 2024 / 09:00PM GMT\n\nOperator\n\n\n\nGood day. Welcome to the East West Bancorp's First Quarter 2024 Earnings Call. (Operator Instructions) Please note, this...",
"url": "https://www.gurufocus.com/news/2416275/q1-2024-east-west-bancorp-inc-earnings-call-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2024-04-24T05:06:01.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EWBC",
"name": "East West Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 165.62292,
"sentiment_score": 0.39225,
"highlights": [
{
"highlight": "Adrienne Atkinson - <em>East</em> <em>West</em> <em>Bancorp</em>, <em>Inc</em>. - Director of IR\n\n\n\nThank you, operator. Good afternoon, and thank you, everyone, for joining us to review East West Bancorp's First Quarter 2024 Financial Results.",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Q1 2024 <em>East</em> <em>West</em> <em>Bancorp</em> <em>Inc</em> Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "8d2eb575-7cc2-4a33-9b83-1c78ac34022b",
"title": "Manhattan Associates Inc (MANH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Advances",
"description": "Total Revenue: $255 million, up 15% year-over-year.Cloud Revenue: $78 million, up 36% year-over-year.Services Revenue: $132 million, up 14% year-over-year.Adju",
"keywords": "GuruFocus, Article, News, GuruFocus Research, MANH",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Could y...",
"url": "https://www.gurufocus.com/news/2416369/manhattan-associates-inc-manh-q1-2024-earnings-call-transcript-highlights-robust-growth-and-strategic-advances",
"image_url": "https://static.gurufocus.com/logos/0C0000087M.png?5",
"language": "en",
"published_at": "2024-04-24T07:15:18.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MANH",
"name": "Manhattan Associates, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 117.35417,
"sentiment_score": 0.693733,
"highlights": [
{
"highlight": "The point-of-sale solution is proving its merit independently, attracting new customers who have not previously engaged with other <em>Manhattan</em> <em>Associates</em>' products.\n\nQ: Could you provide an update on the Shopify partnership, particularly regarding product integration efforts?",
"sentiment": 0.7719,
"highlighted_in": "main_text"
},
{
"highlight": "This partnership aims to align with a potential wave of e-commerce platform replacements, leveraging <em>Manhattan</em> <em>Associates</em>' enterprise-class order management system.\n\nQ: What are the opportunities for partnering with other companies to leverage customer data more effectively as more workflows and data move to the cloud?",
"sentiment": 0.6969,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Manhattan</em> <em>Associates</em> <em>Inc</em> (MANH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Advances",
"sentiment": 0.6124,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "b2aa7a37-1d7d-4148-9b91-2186eb786c5c",
"title": "Clearsign Technologies Corporation (CLIR) Q4 2023 Earnings Call Transcript",
"description": "Clearsign Technologies Corporation (NASDAQ:NASDAQ:CLIR) Q4 2023 Earnings Conference Call April 23, 2024 5:00 PM ETCompany ParticipantsMatthew Selinger -...",
"keywords": "",
"snippet": "Clearsign Technologies Corporation (NASDAQ:CLIR) Q4 2023 Earnings Conference Call April 23, 2024 5:00 PM ET\n\nCompany Participants\n\nMatthew Selinger - Principal\n...",
"url": "https://seekingalpha.com/article/4685515-clearsign-technologies-corporation-clir-q4-2023-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-04-24T02:24:01.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "CLIR",
"name": "ClearSign Technologies Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 162.94803,
"sentiment_score": 0.152933,
"highlights": [
{
"highlight": "<em>Clearsign</em> <em>Technologies</em> <em>Corporation</em> (<em>NASDAQ:CLIR</em>) Q4 2023 Earnings Conference Call April 23, 2024 5:00 PM ET\n\nCompany Participants\n\nMatthew Selinger - Principal\n\nBrent Hinds - VP, Finance\n\nJim Deller - CEO\n\nConference Call Participants\n\nAmit Dayal - H.C. Wainwright & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Welcome, everyone, to the <em>ClearSign</em> <em>Technologies</em> <em>Corporation</em> fourth quarter and full-year 2023 results conference call.\n\nDuring this conference call, the company will make forward-looking statements. Any statement that is not a statement of historical fact is a forward-looking statement.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Clearsign</em> <em>Technologies</em> <em>Corporation</em> (CLIR) Q4 2023 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MLKRI.PA",
"name": "Well SA",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "Financial Services",
"match_score": 4.304894,
"sentiment_score": 0.5272,
"highlights": [
{
"highlight": "Turning to our boiler burner product line, we are happy to report that our first permanent installation in California continues to run <em>well</em>. And we have been using these as demonstration sites prospective customers can visit while looking to purchase.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "We have also formed partnerships with leading global and national equipment manufacturers, which allow our projects we fulfilled for the resources and credentials of these <em>well</em>-established industry stalwarts. And markets are also developing.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "You have back to validation as <em>well</em>. You've completed this financing. So is part of the financing going to go towards just building a sales team internally? I know you have channel partners, but how are you taking a little bit more control of the sales process with all of these developments?\n\nJim Deller\n\nWe are developing our sales capability.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Up until now, it has been -- ClearSign has not been appealing to them, because we were not <em>well</em> known in the industry. And from that perspective, we've been a hard technology to sell. We're now in the process. We've got interest from those third parties.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Jim Deller\n\n<em>Well</em>, thank you, everyone, for your interest and taking the time to participate today. We look forward to updating you regarding our developments and speaking with you on our next call.\n\nOperator\n\nThe conference has now concluded. Thank you for attending today's presentation. You may now disconnect.",
"sentiment": 0.7906,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MLMAD.PA",
"name": "Made SA",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "Technology",
"match_score": 4.608095,
"sentiment_score": 0.599,
"highlights": [
{
"highlight": "The risks and uncertainties associated with the forward-looking statements <em>made</em> in this conference call include, but are not limited to, whether field testing and sales of ClearSign's products will be successfully completed, whether ClearSign will be successful in expanding the market for its products, and other risks that are describing ClearSign's",
"sentiment": 0.7903,
"highlighted_in": "main_text"
},
{
"highlight": "I will start with what may be the most meaningful announcement we have <em>made</em> for our long-term business. On February 13, we announced that following a year-long process of setting operational site equipment review and feedback from industry and other stakeholders.",
"sentiment": 0.3744,
"highlighted_in": "main_text"
},
{
"highlight": "Firstly, this assessment was <em>made</em> considering all equipment operation in California, so providing the technology that sets what is designated the best performance is a meaningful achievement. Additionally, this test equipment has to be operational long term to be considered.",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "We believe that by successfully completing these projects, we have <em>made</em> a powerful statement for ClearSign, significant to both our customer base and also the regional air regulations.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
},
{
"highlight": "A significant component of this development has been a recent investment we have <em>made</em> in our in-house capabilities. Back in November, we announced the hiring of Matthew Martin as our Chief Technology Officer, where we discussed his background and expertise in our last call.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "The other comment I <em>made</em> that it is also worthy of note, the hydrogen producer coming to ClearSign can take it on themselves to request that we go through the process to be evaluated for inclusion in their approved vendor list.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MLWEL.PA",
"name": "Well SA",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "N/A",
"match_score": 4.30492,
"sentiment_score": 0.5272,
"highlights": [
{
"highlight": "Turning to our boiler burner product line, we are happy to report that our first permanent installation in California continues to run <em>well</em>. And we have been using these as demonstration sites prospective customers can visit while looking to purchase.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "We have also formed partnerships with leading global and national equipment manufacturers, which allow our projects we fulfilled for the resources and credentials of these <em>well</em>-established industry stalwarts. And markets are also developing.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "You have back to validation as <em>well</em>. You've completed this financing. So is part of the financing going to go towards just building a sales team internally? I know you have channel partners, but how are you taking a little bit more control of the sales process with all of these developments?\n\nJim Deller\n\nWe are developing our sales capability.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Up until now, it has been -- ClearSign has not been appealing to them, because we were not <em>well</em> known in the industry. And from that perspective, we've been a hard technology to sell. We're now in the process. We've got interest from those third parties.",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Jim Deller\n\n<em>Well</em>, thank you, everyone, for your interest and taking the time to participate today. We look forward to updating you regarding our developments and speaking with you on our next call.\n\nOperator\n\nThe conference has now concluded. Thank you for attending today's presentation. You may now disconnect.",
"sentiment": 0.7906,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0I0B.L",
"name": "ClearSign Technologies Corporation",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 160.04703,
"sentiment_score": 0.152933,
"highlights": [
{
"highlight": "<em>Clearsign</em> <em>Technologies</em> <em>Corporation</em> (NASDAQ:CLIR) Q4 2023 Earnings Conference Call April 23, 2024 5:00 PM ET\n\nCompany Participants\n\nMatthew Selinger - Principal\n\nBrent Hinds - VP, Finance\n\nJim Deller - CEO\n\nConference Call Participants\n\nAmit Dayal - H.C. Wainwright & Co.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Welcome, everyone, to the <em>ClearSign</em> <em>Technologies</em> <em>Corporation</em> fourth quarter and full-year 2023 results conference call.\n\nDuring this conference call, the company will make forward-looking statements. Any statement that is not a statement of historical fact is a forward-looking statement.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Clearsign</em> <em>Technologies</em> <em>Corporation</em> (CLIR) Q4 2023 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "b1a745c6-9ec5-41e9-bd90-71cc6946fef5",
"title": "Hawaiian Holdings Inc (HA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Through Market Challenges with Strategic Growth",
"description": "Total Revenue: Increased by 5.4%.Capacity: Grew by 2.7% compared to the same period in 2023.Resin (Revenue per Available Seat Mile): Up 2.6% year-over-year.Anc",
"keywords": "GuruFocus, Article, News, GuruFocus Research, HA",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Can you...",
"url": "https://www.gurufocus.com/news/2416367/hawaiian-holdings-inc-ha-q1-2024-earnings-call-transcript-highlights-navigating-through-market-challenges-with-strategic-growth",
"image_url": "https://static.gurufocus.com/logos/0C00000B81.png?5",
"language": "en",
"published_at": "2024-04-24T07:15:13.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HA",
"name": "Hawaiian Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 98.82119,
"sentiment_score": 0.4404,
"highlights": [
{
"highlight": "<em>Hawaiian</em> <em>Holdings</em> <em>Inc</em> (HA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Through Market Challenges with Strategic Growth",
"sentiment": 0.4404,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "f0d08bbc-517c-4b31-b861-ab1d7ea5935a",
"title": "Mattel Inc (MAT) Q1 2024 Earnings Call Transcript Highlights: Robust Margin Growth and Strategic Share Repurchases",
"description": "Net Sales: $810 million, declined 1% as reported and in constant currency.Adjusted Gross Margin: Increased by 830 basis points to 48.3%.Adjusted EBITDA: Improv",
"keywords": "GuruFocus, Article, News, GuruFocus Research, MAT",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Can you...",
"url": "https://www.gurufocus.com/news/2416366/mattel-inc-mat-q1-2024-earnings-call-transcript-highlights-robust-margin-growth-and-strategic-share-repurchases",
"image_url": "https://static.gurufocus.com/logos/0C00000899.png?5",
"language": "en",
"published_at": "2024-04-24T07:14:19.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MAT",
"name": "Mattel, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 68.08339,
"sentiment_score": 0.665271,
"highlights": [
{
"highlight": "DiSilvestro - CFO, <em>Mattel</em>, <em>Inc</em>.) The timing of Easter did not materially impact our year-on-year shipment in the first quarter. POS for the total company was up low single digits in Q1, with improving trends as we move through the quarter, including some likely benefit from the holiday timing.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "A: (Ynon Kreiz - CEO, <em>Mattel</em>, <em>Inc</em>.) Hot Wheels has been growing for 6 consecutive years and is on track to grow again in 2024. The growth is driven by great product innovation, expanding into adult collectors, broadening distribution, and more content coming onto Netflix.",
"sentiment": 0.875,
"highlighted_in": "main_text"
},
{
"highlight": "DiSilvestro - CFO, <em>Mattel</em>, <em>Inc</em>.) It's primarily the wrap from the introduction last year, the pipeline fill. Importantly, the POS for the line is positive in the first quarter, and we're very optimistic about the future for that line.\n\nQ: Regarding buybacks, cash flow showed nice improvement for the quarter.",
"sentiment": 0.9226,
"highlighted_in": "main_text"
},
{
"highlight": "DiSilvestro - CFO, <em>Mattel</em>, <em>Inc</em>.) We're not giving specific guidance around our share repurchases, but we continue to execute against our stated capital allocation priorities. We resumed repurchases last year and announced a new $1 billion program earlier this year.",
"sentiment": 0.1014,
"highlighted_in": "main_text"
},
{
"highlight": "DiSilvestro - CFO, <em>Mattel</em>, <em>Inc</em>.) In the first quarter, we achieved significant gross margin expansion. We expect to continue benefiting from cost savings and will also benefit from increased production levels. There's an absorption benefit as we wrap last year's reduction of owned inventory levels.",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "A: (Ynon Kreiz - CEO, <em>Mattel</em>, <em>Inc</em>.) Barbie is an incredible brand and has never been more relevant or connected to pop culture. We are celebrating the 65th anniversary for Barbie with multiple activations. We expect more shelf space in the second half and are expanding into the adult collector line.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Mattel</em> <em>Inc</em> (MAT) Q1 2024 Earnings Call Transcript Highlights: Robust Margin Growth and Strategic Share Repurchases",
"sentiment": 0.7351,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "f1c38017-eb9d-434e-942e-70a9a5e7fdde",
"title": "SmartFinancial Inc (SMBK) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and Strategic Insights",
"description": "Net Income: $9.4 million for the quarter, with earnings per diluted share at $0.55.Operating Net Income: $8.4 million, or $0.49 per diluted share.Tangible Book",
"keywords": "GuruFocus, Article, News, GuruFocus Research, SMBK",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Can you...",
"url": "https://www.gurufocus.com/news/2416347/smartfinancial-inc-smbk-q1-2024-earnings-call-transcript-highlights-robust-growth-and-strategic-insights",
"image_url": "https://static.gurufocus.com/logos/0C00000YF7.png?5",
"language": "en",
"published_at": "2024-04-24T07:09:53.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SMBK",
"name": "SmartFinancial, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 87.726906,
"sentiment_score": 0.6124,
"highlights": [
{
"highlight": "<em>SmartFinancial</em> <em>Inc</em> (SMBK) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth and Strategic Insights",
"sentiment": 0.6124,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "242a28bc-decd-4e39-9318-340ac05094b7",
"title": "Preferred Bank (PFBC) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and Strategic Expansions",
"description": "Net Income: $33.5 millionEarnings Per Share (EPS): $2.44 per fully diluted shareLoan Growth: Annualized at 4%Deposit Growth: Annualized at 6.5%Net Interest Mar",
"keywords": "GuruFocus, Article, News, GuruFocus Research, PFBC",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Can you...",
"url": "https://www.gurufocus.com/news/2416362/preferred-bank-pfbc-q1-2024-earnings-call-transcript-highlights-strong-performance-and-strategic-expansions",
"image_url": "https://static.gurufocus.com/logos/0C000008KI.png?5",
"language": "en",
"published_at": "2024-04-24T07:14:04.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFBC",
"name": "Preferred Bank",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 83.97792,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "<em>Preferred</em> <em>Bank</em> (PFBC) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and Strategic Expansions",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "c5d75e07-038d-43ea-86bc-634dd81ba179",
"title": "Independent Bank Group Inc (IBTX) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and Financial Performance",
"description": "Adjusted Net Income: $26 million or $0.63 per diluted shareNet Income: $24.2 million or $0.58 per diluted shareNet Interest Margin (NIM): Compressed by 7 basis",
"keywords": "GuruFocus, Article, News, GuruFocus Research, IBTX",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: With th...",
"url": "https://www.gurufocus.com/news/2416325/independent-bank-group-inc-ibtx-q1-2024-earnings-call-transcript-highlights-strategic-insights-and-financial-performance",
"image_url": "https://static.gurufocus.com/logos/0C00009ULO.png?5",
"language": "en",
"published_at": "2024-04-24T07:04:47.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IBTX",
"name": "Independent Bank Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 105.3338,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Independent</em> <em>Bank</em> <em>Group</em> <em>Inc</em> (IBTX) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and Financial Performance",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "c7150d99-7c59-4bc9-98a2-104cbe207aea",
"title": "Enterprise Financial Services Corp (EFSC) (Q1 2024) Earnings Call Transcript Highlights: Strong Performance with Notable Growth in Key Financial Metrics",
"description": "Net Income: $40.4 millionEarnings Per Share (EPS): $1.05 per diluted shareAdjusted Return on Average Assets (ROAA): 1.14%Pre-Provision Net Revenue ROAA: 1.58%N",
"keywords": "GuruFocus, Article, News, GuruFocus Research, EFSC",
"snippet": "Release Date: April 23, 2024\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nQ & A Highlights\n\nQ: Jeff, I...",
"url": "https://www.gurufocus.com/news/2416357/enterprise-financial-services-corp-efsc-q1-2024-earnings-call-transcript-highlights-strong-performance-with-notable-growth-in-key-financial-metrics",
"image_url": "https://static.gurufocus.com/logos/0C000007GW.png?5",
"language": "en",
"published_at": "2024-04-24T07:13:08.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "EFSC",
"name": "Enterprise Financial Services Corp",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 116.627556,
"sentiment_score": 0.7096,
"highlights": [
{
"highlight": "<em>Enterprise</em> <em>Financial</em> <em>Services</em> <em>Corp</em> (EFSC) (Q1 2024) Earnings Call Transcript Highlights: Strong Performance with Notable Growth in Key Financial Metrics",
"sentiment": 0.7096,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "804eaa81-a663-4367-9c44-dd1181fb6946",
"title": "Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair By Investing.com",
"description": "Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair",
"keywords": "",
"snippet": "Ms. Chhabra Karson brings highly successful 20-year track record in industry leadership roles\n\n\n\nCambridge, UK, April 24 2024: Harness Therapeutics, a biotechno...",
"url": "https://www.investing.com/news/press-releases/harness-therapeutics-appoints-seasoned-biopharmaceutical-leader-ms-meenu-chhabra-karson-as-board-chair-93CH-3392764",
"image_url": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
"language": "en",
"published_at": "2024-04-24T07:12:06.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "MGNX",
"name": "MacroGenics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.15526,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Chhabra Karson has also served on the board of <em>Macrogenics</em> (MGNX) and is a member of its audit committee. Her previous board appointments include Chair of Apexigen (APGN), sold to Pyxis Oncology (PYXS); Chair of Audit Committee of Vallon, sold to GRI Biotech (GRI); and Chair of Audit Committee of Fore Bio. Ms.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PTI",
"name": "Proteostasis Therapeutics Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 34.078186,
"sentiment_score": 0.4019,
"highlights": [
{
"highlight": "Chhabra Karson has also served as a biotech CEO for 15 years at <em>Proteostasis</em> <em>Therapeutics</em> (NASDAQ: ) (<em>NASDAQ:PTI</em>) and Allozyne, Inc. and was Chief Business Officer at BioXell SpA, (SWX:BXLN). Earlier in her career, she held roles of increasing responsibility at Novartis (SIX: ), latterly VP Business Development.\n\nhere or remove ads . 3rd party Ad.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "6551e56a-2296-4460-949a-fa12c0182532",
"title": "CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI ® (sparsentan) for the treatment of IgA Nephropathy By Investing.com",
"description": "CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI ® (sparsentan) for the treatment of IgA Nephropathy",
"keywords": "",
"snippet": "First non-immunosuppressive therapy for the treatment of IgA Nephropathy (IgAN) approved in Europe\n\nConditional marketing authorization is based on statisticall...",
"url": "https://www.investing.com/news/press-releases/csl-vifor-and-travere-therapeutics-announce-european-commission-approves-filspari--sparsentan-for-the-treatment-of-iga-nephropathy-93CH-3392765",
"image_url": "https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg",
"language": "en",
"published_at": "2024-04-24T07:12:05.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "TVTX",
"name": "Travere Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 72.27829,
"sentiment_score": 0.44044,
"highlights": [
{
"highlight": "GALLEN , Switzerland and SAN DIEGO, April 24, 2024 /PRNewswire/ -- CSL Vifor and <em>Travere</em> <em>Therapeutics</em>, <em>Inc</em>., (<em>NASDAQ</em>: <em>TVTX</em>) today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the treatment of adults with primary IgAN with a urine protein excretion ‰¥1.0 g/day (or urine protein-to-creatinine",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "\"As the first and only non-immunosuppressive therapy approved for IgAN, we believe FILSPARI offers clinicians the potential for a new foundational treatment for this rare kidney disease, replacing RAAS inhibition,\" said Eric Dube , Ph.D., President and Chief Executive Officer, <em>Travere</em> <em>Therapeutics</em>.",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Travere</em> <em>Therapeutics</em>\n\nAt <em>Travere</em> <em>Therapeutics</em>, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "FILSPARI was developed by <em>Travere</em> <em>Therapeutics</em> and has been granted Orphan Drug Designation for the treatment of IgAN in Europe and the U.S. FILSPARI is currently available in the U.S. and was granted accelerated approval by the US Food and Drug Administration in February 2023 based on reduction in proteinuria.",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "CSL Vifor and <em>Travere</em> <em>Therapeutics</em> Announce European Commission approves FILSPARI ® (sparsentan) for the treatment of IgA Nephropathy By Investing.com",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 1884,
"sentiment_avg": 0.2469028018193813
}
]
}
Other details
Country
- us
- 5,275